Alerce Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-356,270
| Closed | -$24.3M | – | 7 |
|
|
2022
Q3 | $24.3M | Buy |
356,270
+230,000
| +182% | +$15.7M | 23.36% | 3 |
|
|
2022
Q2 | $4.03M | Hold |
126,270
| – | – | 7.49% | 6 |
|
|
2022
Q1 | $4.37M | Hold |
126,270
| – | – | 7.41% | 6 |
|
|
2021
Q4 | $3.7M | Hold |
126,270
| – | – | 3.76% | 7 |
|
|
2021
Q3 | $3.22M | Hold |
126,270
| – | – | 2.2% | 7 |
|
|
2021
Q2 | $4.42M | Hold |
126,270
| – | – | 2.4% | 7 |
|
|
2021
Q1 | $5.15M | Hold |
126,270
| – | – | 2.28% | 7 |
|
|
2020
Q4 | $5.47M | Buy |
+126,270
| New | +$5.47M | 2.15% | 7 |
|